MyFinsight

HomeCompareBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Cash and cashequivalents$50,644K Short-term investments$40,674K Inventories$3,384K Prepaid expenses andother current assets$1,776K Accounts receivable, net$347K Total current assets$96,825K Long-term investments$4,012K Other assets$241K Accumulated deficit-$1,709,271K Accumulated othercomprehensive loss-$1,188K Total assets$101,078K Total stockholders'deficit attributable to...-$30,144K Additional paid-in capital$1,680,274K Common stock, 0.01 parvalue 225,000 shares...$41K Total liabilities,redeemable...$101,078K Total deficit-$29,624K Nonredeemablenon-controlling interests$520K Total liabilities$109,222K Redeemablenon-controlling interests$21,480K Liability related to saleof future...$70,495K Total currentliabilities$36,040K Deferred revenue, net ofcurrent$2,620K Other long-termliabilities$67K Accrued and othercurrent liabilities$23,112K Accounts payable$7,510K Deferred revenue$5,418K
Balance Sheet

KYNTRA BIO, INC. (KYNB)

KYNTRA BIO, INC. (KYNB)

source: myfinsight.com